Gout
Conditions
Interventions
The control group:febuxostat
The treatment group:Qingming decoction ( granules ) + febuxostat
Sponsors
Yunnan Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients with gout diagnosis;(2) Patients with gout intermittency diagnostic criteria: past history of gout, and is not in acute onset of gout, blood uric acid value: male=420µmol/L(7mg/dl), female=360µmol/L(6mg/dl); (3) Those who meet the TCM diagnostic criteria of gout qi deficiency and dampness accumulation syndrome; (4) Those aged between 18 and 65 years old; (5) Patients who did not have acute gout attack 2 weeks before joining the group, did not take non-buxostat and other uric acid-lowering drugs within 2 weeks, and did not take hormone drugs within 1 month; (6) Patients who did not participate in other clinical drug trials and voluntarily participated in this trial signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who do not meet the above inclusion criteria; (2) Patients with acute gouty arthritis at screening; (3) Secondary gout, such as secondary to kidney disease, blood diseases; (4) Patients with diseases that affect basic survival, such as AIDS and malignant tumors; (5) pregnant women, lactating women or women who may be pregnant; (6) Blood ALT, AST, Cr beyond the normal value of 1.5 times or more; (7) patients with allergic constitution and allergic to the drugs used in this study; (8) persons with alcohol, drug or substance abuse; (9) Patients who were receiving treatment with thiopurine and mercaptopurine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BMI;Routine Urine Test;Renal Function;blood lipids;Blood Routine Examination;Stool OB;Stool Routine Examination;Liver Function;TCM syndrome scoring;the SF-36 scale; | — |
Countries
China
Contacts
Public ContactXiaohu Tang
Outcome results
None listed